nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0573	0.0745	CbGbCtD
Norfloxacin—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0464	0.0602	CbGbCtD
Norfloxacin—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0434	0.0564	CbGbCtD
Norfloxacin—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0305	0.0396	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0287	0.0372	CbGbCtD
Norfloxacin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0287	0.0372	CbGbCtD
Norfloxacin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0247	0.0321	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0247	0.0321	CbGbCtD
Norfloxacin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.024	0.0312	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.024	0.0312	CbGbCtD
Norfloxacin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0238	0.0309	CbGbCtD
Norfloxacin—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0228	0.0296	CbGbCtD
Norfloxacin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Norfloxacin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0217	0.0282	CbGbCtD
Norfloxacin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0215	0.0279	CbGbCtD
Norfloxacin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0215	0.0279	CbGbCtD
Norfloxacin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0188	0.0244	CbGbCtD
Norfloxacin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0186	0.0241	CbGbCtD
Norfloxacin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.018	0.0234	CbGbCtD
Norfloxacin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0177	0.023	CbGbCtD
Norfloxacin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0177	0.023	CbGbCtD
Norfloxacin—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0177	0.0229	CbGbCtD
Norfloxacin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0163	0.0212	CbGbCtD
Norfloxacin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0163	0.0212	CbGbCtD
Norfloxacin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.016	0.0208	CbGbCtD
Norfloxacin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0174	CbGbCtD
Norfloxacin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0158	CbGbCtD
Norfloxacin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00986	0.0128	CbGbCtD
Norfloxacin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00927	0.012	CbGbCtD
Norfloxacin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00927	0.012	CbGbCtD
Norfloxacin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00838	0.0109	CbGbCtD
Norfloxacin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00838	0.0109	CbGbCtD
Norfloxacin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00724	0.0094	CbGbCtD
Norfloxacin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00703	0.00913	CbGbCtD
Norfloxacin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00635	0.00825	CbGbCtD
Norfloxacin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00635	0.00825	CbGbCtD
Norfloxacin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00609	0.00791	CbGbCtD
Norfloxacin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.000803	0.271	CbGdCrCtD
Norfloxacin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000735	0.248	CbGdCrCtD
Norfloxacin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000735	0.248	CbGdCrCtD
Norfloxacin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000646	0.0552	CbGeAlD
Norfloxacin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000623	0.0532	CbGeAlD
Norfloxacin—TOP2A—blood—acquired immunodeficiency syndrome	0.000493	0.0421	CbGeAlD
Norfloxacin—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.000477	0.0408	CbGeAlD
Norfloxacin—Gatifloxacin—ALB—acquired immunodeficiency syndrome	0.000475	1	CrCbGaD
Norfloxacin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000467	0.0399	CbGeAlD
Norfloxacin—TOP2A—vagina—acquired immunodeficiency syndrome	0.000457	0.039	CbGeAlD
Norfloxacin—TOP2A—lung—acquired immunodeficiency syndrome	0.000432	0.0369	CbGeAlD
Norfloxacin—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000417	0.0357	CbGeAlD
Norfloxacin—CYP2A6—lung—acquired immunodeficiency syndrome	0.000395	0.0337	CbGeAlD
Norfloxacin—SLC22A5—retina—acquired immunodeficiency syndrome	0.00039	0.0333	CbGeAlD
Norfloxacin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.122	CbGdCrCtD
Norfloxacin—SLC22A6—brain—acquired immunodeficiency syndrome	0.000358	0.0306	CbGeAlD
Norfloxacin—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000343	0.0293	CbGeAlD
Norfloxacin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.112	CbGdCrCtD
Norfloxacin—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000306	0.0262	CbGeAlD
Norfloxacin—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000296	0.0253	CbGeAlD
Norfloxacin—CYP2A6—brain—acquired immunodeficiency syndrome	0.000279	0.0239	CbGeAlD
Norfloxacin—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000274	0.0234	CbGeAlD
Norfloxacin—SLC22A5—blood—acquired immunodeficiency syndrome	0.000261	0.0223	CbGeAlD
Norfloxacin—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000251	0.0215	CbGeAlD
Norfloxacin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000248	0.0212	CbGeAlD
Norfloxacin—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000245	0.0209	CbGeAlD
Norfloxacin—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000242	0.0207	CbGeAlD
Norfloxacin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000239	0.0205	CbGeAlD
Norfloxacin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000236	0.0202	CbGeAlD
Norfloxacin—CYP1A1—blood—acquired immunodeficiency syndrome	0.000233	0.0199	CbGeAlD
Norfloxacin—SLC22A5—lung—acquired immunodeficiency syndrome	0.000229	0.0196	CbGeAlD
Norfloxacin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000228	0.0195	CbGeAlD
Norfloxacin—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000216	0.0185	CbGeAlD
Norfloxacin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000211	0.0181	CbGeAlD
Norfloxacin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000207	0.0177	CbGeAlD
Norfloxacin—CYP1A1—lung—acquired immunodeficiency syndrome	0.000204	0.0175	CbGeAlD
Norfloxacin—CYP3A5—lung—acquired immunodeficiency syndrome	0.0002	0.0171	CbGeAlD
Norfloxacin—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000189	0.0162	CbGeAlD
Norfloxacin—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000182	0.0156	CbGeAlD
Norfloxacin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00018	0.0154	CbGeAlD
Norfloxacin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000171	0.0146	CbGeAlD
Norfloxacin—SLC22A5—brain—acquired immunodeficiency syndrome	0.000162	0.0138	CbGeAlD
Norfloxacin—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000157	0.0134	CbGeAlD
Norfloxacin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00069	CcSEcCtD
Norfloxacin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000689	CcSEcCtD
Norfloxacin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000148	0.000689	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000689	CcSEcCtD
Norfloxacin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000688	CcSEcCtD
Norfloxacin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000147	0.000685	CcSEcCtD
Norfloxacin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000147	0.000685	CcSEcCtD
Norfloxacin—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000685	CcSEcCtD
Norfloxacin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000684	CcSEcCtD
Norfloxacin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000684	CcSEcCtD
Norfloxacin—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000684	CcSEcCtD
Norfloxacin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000683	CcSEcCtD
Norfloxacin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000681	CcSEcCtD
Norfloxacin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000146	0.000679	CcSEcCtD
Norfloxacin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000679	CcSEcCtD
Norfloxacin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000679	CcSEcCtD
Norfloxacin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000146	0.000679	CcSEcCtD
Norfloxacin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000145	0.000675	CcSEcCtD
Norfloxacin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000674	CcSEcCtD
Norfloxacin—CYP1A1—brain—acquired immunodeficiency syndrome	0.000145	0.0124	CbGeAlD
Norfloxacin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000673	CcSEcCtD
Norfloxacin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000672	CcSEcCtD
Norfloxacin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000671	CcSEcCtD
Norfloxacin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000671	CcSEcCtD
Norfloxacin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.00067	CcSEcCtD
Norfloxacin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00067	CcSEcCtD
Norfloxacin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000669	CcSEcCtD
Norfloxacin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000667	CcSEcCtD
Norfloxacin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000666	CcSEcCtD
Norfloxacin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000665	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000665	CcSEcCtD
Norfloxacin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000664	CcSEcCtD
Norfloxacin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000663	CcSEcCtD
Norfloxacin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000142	0.000662	CcSEcCtD
Norfloxacin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000661	CcSEcCtD
Norfloxacin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000661	CcSEcCtD
Norfloxacin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000659	CcSEcCtD
Norfloxacin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000659	CcSEcCtD
Norfloxacin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000659	CcSEcCtD
Norfloxacin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000657	CcSEcCtD
Norfloxacin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000657	CcSEcCtD
Norfloxacin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000652	CcSEcCtD
Norfloxacin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000652	CcSEcCtD
Norfloxacin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000651	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000651	CcSEcCtD
Norfloxacin—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.00014	0.012	CbGeAlD
Norfloxacin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00065	CcSEcCtD
Norfloxacin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000646	CcSEcCtD
Norfloxacin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000139	0.0119	CbGeAlD
Norfloxacin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000646	CcSEcCtD
Norfloxacin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000646	CcSEcCtD
Norfloxacin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000646	CcSEcCtD
Norfloxacin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000645	CcSEcCtD
Norfloxacin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000643	CcSEcCtD
Norfloxacin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000643	CcSEcCtD
Norfloxacin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000642	CcSEcCtD
Norfloxacin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000641	CcSEcCtD
Norfloxacin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000138	0.00064	CcSEcCtD
Norfloxacin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000138	0.00064	CcSEcCtD
Norfloxacin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000639	CcSEcCtD
Norfloxacin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000637	CcSEcCtD
Norfloxacin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000637	CcSEcCtD
Norfloxacin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000636	CcSEcCtD
Norfloxacin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000635	CcSEcCtD
Norfloxacin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000634	CcSEcCtD
Norfloxacin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000634	CcSEcCtD
Norfloxacin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000634	CcSEcCtD
Norfloxacin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000632	CcSEcCtD
Norfloxacin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000632	CcSEcCtD
Norfloxacin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000136	0.00063	CcSEcCtD
Norfloxacin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000629	CcSEcCtD
Norfloxacin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000623	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000623	CcSEcCtD
Norfloxacin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000134	0.0114	CbGeAlD
Norfloxacin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000621	CcSEcCtD
Norfloxacin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000621	CcSEcCtD
Norfloxacin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.00062	CcSEcCtD
Norfloxacin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000619	CcSEcCtD
Norfloxacin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000618	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000618	CcSEcCtD
Norfloxacin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000618	CcSEcCtD
Norfloxacin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000616	CcSEcCtD
Norfloxacin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000132	0.000616	CcSEcCtD
Norfloxacin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000616	CcSEcCtD
Norfloxacin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000614	CcSEcCtD
Norfloxacin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000613	CcSEcCtD
Norfloxacin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000611	CcSEcCtD
Norfloxacin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000611	CcSEcCtD
Norfloxacin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000611	CcSEcCtD
Norfloxacin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00061	CcSEcCtD
Norfloxacin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000609	CcSEcCtD
Norfloxacin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000609	CcSEcCtD
Norfloxacin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000608	CcSEcCtD
Norfloxacin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000608	CcSEcCtD
Norfloxacin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00013	0.000607	CcSEcCtD
Norfloxacin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000605	CcSEcCtD
Norfloxacin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000605	CcSEcCtD
Norfloxacin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000605	CcSEcCtD
Norfloxacin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000603	CcSEcCtD
Norfloxacin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000602	CcSEcCtD
Norfloxacin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000602	CcSEcCtD
Norfloxacin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000601	CcSEcCtD
Norfloxacin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000598	CcSEcCtD
Norfloxacin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000598	CcSEcCtD
Norfloxacin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.000596	CcSEcCtD
Norfloxacin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000596	CcSEcCtD
Norfloxacin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000595	CcSEcCtD
Norfloxacin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000594	CcSEcCtD
Norfloxacin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000592	CcSEcCtD
Norfloxacin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000591	CcSEcCtD
Norfloxacin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000591	CcSEcCtD
Norfloxacin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000127	0.00059	CcSEcCtD
Norfloxacin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000589	CcSEcCtD
Norfloxacin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000589	CcSEcCtD
Norfloxacin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000589	CcSEcCtD
Norfloxacin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000588	CcSEcCtD
Norfloxacin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.000588	CcSEcCtD
Norfloxacin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000586	CcSEcCtD
Norfloxacin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000586	CcSEcCtD
Norfloxacin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000585	CcSEcCtD
Norfloxacin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000584	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000584	CcSEcCtD
Norfloxacin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000583	CcSEcCtD
Norfloxacin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000581	CcSEcCtD
Norfloxacin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000125	0.00058	CcSEcCtD
Norfloxacin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00058	CcSEcCtD
Norfloxacin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00058	CcSEcCtD
Norfloxacin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00058	CcSEcCtD
Norfloxacin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000577	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000576	CcSEcCtD
Norfloxacin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.000575	CcSEcCtD
Norfloxacin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000575	CcSEcCtD
Norfloxacin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000572	CcSEcCtD
Norfloxacin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000568	CcSEcCtD
Norfloxacin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000567	CcSEcCtD
Norfloxacin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000567	CcSEcCtD
Norfloxacin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000565	CcSEcCtD
Norfloxacin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000565	CcSEcCtD
Norfloxacin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000563	CcSEcCtD
Norfloxacin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000563	CcSEcCtD
Norfloxacin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000562	CcSEcCtD
Norfloxacin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000561	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000559	CcSEcCtD
Norfloxacin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000557	CcSEcCtD
Norfloxacin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000557	CcSEcCtD
Norfloxacin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000556	CcSEcCtD
Norfloxacin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000556	CcSEcCtD
Norfloxacin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000555	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000554	CcSEcCtD
Norfloxacin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000553	CcSEcCtD
Norfloxacin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00055	CcSEcCtD
Norfloxacin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000549	CcSEcCtD
Norfloxacin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000547	CcSEcCtD
Norfloxacin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000546	CcSEcCtD
Norfloxacin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000545	CcSEcCtD
Norfloxacin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000543	CcSEcCtD
Norfloxacin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000542	CcSEcCtD
Norfloxacin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000542	CcSEcCtD
Norfloxacin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000541	CcSEcCtD
Norfloxacin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00054	CcSEcCtD
Norfloxacin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.00054	CcSEcCtD
Norfloxacin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.00054	CcSEcCtD
Norfloxacin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000538	CcSEcCtD
Norfloxacin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000535	CcSEcCtD
Norfloxacin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000535	CcSEcCtD
Norfloxacin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000529	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000529	CcSEcCtD
Norfloxacin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000526	CcSEcCtD
Norfloxacin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000525	CcSEcCtD
Norfloxacin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000524	CcSEcCtD
Norfloxacin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000521	CcSEcCtD
Norfloxacin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000521	CcSEcCtD
Norfloxacin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00052	CcSEcCtD
Norfloxacin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000517	CcSEcCtD
Norfloxacin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000517	CcSEcCtD
Norfloxacin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000517	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000517	CcSEcCtD
Norfloxacin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000516	CcSEcCtD
Norfloxacin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000512	CcSEcCtD
Norfloxacin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000512	CcSEcCtD
Norfloxacin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000512	CcSEcCtD
Norfloxacin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000511	CcSEcCtD
Norfloxacin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000509	CcSEcCtD
Norfloxacin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000505	CcSEcCtD
Norfloxacin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000504	CcSEcCtD
Norfloxacin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000503	CcSEcCtD
Norfloxacin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000502	CcSEcCtD
Norfloxacin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000501	CcSEcCtD
Norfloxacin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.0005	CcSEcCtD
Norfloxacin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000107	0.0005	CcSEcCtD
Norfloxacin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0005	CcSEcCtD
Norfloxacin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0005	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000497	CcSEcCtD
Norfloxacin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000496	CcSEcCtD
Norfloxacin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.00049	CcSEcCtD
Norfloxacin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000489	CcSEcCtD
Norfloxacin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000483	CcSEcCtD
Norfloxacin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000483	CcSEcCtD
Norfloxacin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000483	CcSEcCtD
Norfloxacin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000481	CcSEcCtD
Norfloxacin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000481	CcSEcCtD
Norfloxacin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000481	CcSEcCtD
Norfloxacin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000478	CcSEcCtD
Norfloxacin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000477	CcSEcCtD
Norfloxacin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000476	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000474	CcSEcCtD
Norfloxacin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000474	CcSEcCtD
Norfloxacin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000472	CcSEcCtD
Norfloxacin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000468	CcSEcCtD
Norfloxacin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000466	CcSEcCtD
Norfloxacin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000461	CcSEcCtD
Norfloxacin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.86e-05	0.000459	CcSEcCtD
Norfloxacin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.86e-05	0.000459	CcSEcCtD
Norfloxacin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.76e-05	0.000454	CcSEcCtD
Norfloxacin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.75e-05	0.000453	CcSEcCtD
Norfloxacin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.000452	CcSEcCtD
Norfloxacin—Rash—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.00045	CcSEcCtD
Norfloxacin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.67e-05	0.00045	CcSEcCtD
Norfloxacin—Nausea—Indinavir—acquired immunodeficiency syndrome	9.65e-05	0.000449	CcSEcCtD
Norfloxacin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.63e-05	0.000448	CcSEcCtD
Norfloxacin—Headache—Efavirenz—acquired immunodeficiency syndrome	9.62e-05	0.000447	CcSEcCtD
Norfloxacin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.61e-05	0.000447	CcSEcCtD
Norfloxacin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.38e-05	0.000436	CcSEcCtD
Norfloxacin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.34e-05	0.000434	CcSEcCtD
Norfloxacin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000432	CcSEcCtD
Norfloxacin—Rash—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.000431	CcSEcCtD
Norfloxacin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.25e-05	0.00043	CcSEcCtD
Norfloxacin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.25e-05	0.00043	CcSEcCtD
Norfloxacin—Headache—Delavirdine—acquired immunodeficiency syndrome	9.2e-05	0.000428	CcSEcCtD
Norfloxacin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.19e-05	0.000427	CcSEcCtD
Norfloxacin—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.12e-05	0.000424	CcSEcCtD
Norfloxacin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.000418	CcSEcCtD
Norfloxacin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.95e-05	0.000416	CcSEcCtD
Norfloxacin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.000416	CcSEcCtD
Norfloxacin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.000411	CcSEcCtD
Norfloxacin—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.73e-05	0.000406	CcSEcCtD
Norfloxacin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000402	CcSEcCtD
Norfloxacin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.64e-05	0.000402	CcSEcCtD
Norfloxacin—Rash—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.000398	CcSEcCtD
Norfloxacin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.56e-05	0.000398	CcSEcCtD
Norfloxacin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.000397	CcSEcCtD
Norfloxacin—Headache—Ritonavir—acquired immunodeficiency syndrome	8.51e-05	0.000396	CcSEcCtD
Norfloxacin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.31e-05	0.000387	CcSEcCtD
Norfloxacin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000384	CcSEcCtD
Norfloxacin—Rash—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.000383	CcSEcCtD
Norfloxacin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.000383	CcSEcCtD
Norfloxacin—Headache—Saquinavir—acquired immunodeficiency syndrome	8.19e-05	0.000381	CcSEcCtD
Norfloxacin—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.07e-05	0.000375	CcSEcCtD
Norfloxacin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.93e-05	0.000369	CcSEcCtD
Norfloxacin—Rash—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000366	CcSEcCtD
Norfloxacin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000366	CcSEcCtD
Norfloxacin—Headache—Lamivudine—acquired immunodeficiency syndrome	7.81e-05	0.000363	CcSEcCtD
Norfloxacin—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.77e-05	0.000361	CcSEcCtD
Norfloxacin—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.41e-05	0.000345	CcSEcCtD
